Grants for City or township governments - Food and Nutrition

This funding opportunity provides financial support to nonprofit organizations and government agencies to create projects that incentivize SNAP households to purchase and consume healthy fluid milk.

The purpose of this funding opportunity announcement (FOA) is to fund innovative research that will strengthen and advance minority health and health equity objectives.Areas of interest include:Proposals that focus on advancing equity in clinical trials by supporting efforts to advance diversity in clinical trials, equitable data efforts by increasing data available on diverse groups including, but not limited to, ethnicity, race, age, disability and geography, and equity of voices by increasing understanding of diverse patient perspectives, preferences, and unmet needs.

The Jackson County Community Foundation is offering community grants to qualified charitable organizations that serve the local community within Jackson County, North Carolina. This grant program aligns with the foundation's mission to address a broad range of local needs, supporting essential services and development within the community. The grants are intended to foster local initiatives that improve the well-being of residents and strengthen community infrastructure across various sectors. The target beneficiaries of this grant program are diverse, encompassing individuals and groups benefiting from human services, education, youth development, health, food/nutrition, and arts programs. The impact goals are to meet a wide array of community needs, providing support to vulnerable populations, enhancing educational opportunities, promoting healthy lifestyles, and enriching cultural experiences. The foundation prioritizes organizations that are 501(c)(3) public charities, local governments (including public schools), fire and rescue departments, and religious entities engaged in social outreach programs. The program focuses on funding initiatives that provide tangible benefits to the community-at-large, with a particular emphasis on services that are accessible and non-discriminatory. Expected outcomes include improved access to essential services, enhanced community programs, and a strengthened local support network. While specific measurable results are not explicitly detailed beyond the range of grants, the implied results are the successful implementation of programs in the areas of human services, education, youth development, health, food/nutrition, and arts. The Jackson County Community Foundation's strategic priorities are to address local needs comprehensively through community-focused grantmaking. Their theory of change appears to be that by funding a diverse range of charitable organizations and public service entities, they can collectively create a more resilient, educated, healthy, and culturally vibrant community. The grant size typically ranges from $1,000 to $3,000, indicating a focus on supporting numerous local projects rather than a few large-scale initiatives.

This grant provides funding to nonprofit organizations, educational institutions, and government entities in Central New Mexico to develop innovative programs that improve food security for students and their families within educational settings.

This grant provides financial support for music education programs and resources for children 18 and under in Grand Forks County, North Dakota.

The purpose of this funding opportunity is to support the research and development necessary to advance non-invasive (e.g., quantitative tomography-based) technologies, including the development of apparatus, methods, study designs, and methods of data analysis, to characterize and compare the rate and extent to which a topically applied drug becomes available at or near a site of action within the skin in vivo. The expectation is that the funded work will produce an accurate, sensitive and reproducible approach that rapidly measures the (relative) amount of drug present in the skin at a series of depths below the skin surface, which can be utilized to monitor the cutaneous pharmacokinetics (PK) of the drug at selected depths (e.g., in the epidermis) by repeated, serial measurements over time. The intent is to support the eventual development of an alternative, scientifically valid, in vivo cutaneous PK-based approach that can be used to efficiently demonstrate the bioequivalence (BE) of topical products.

The purpose of the funding opportunity is to expand and advance FDA's Office of Minority Health and Health Equity (OMHHE) work with stakeholders and partners for education, outreach, and public awareness activities on potential risks from skin lightening products containing hydroquinone and/or mercury.Applicants will research and propose innovative and community-based strategies and activities that have the potential to strengthen the science base for education and public health awareness on the use of and potential risks from over-the-counter (OTC) skin lightening products.

The Green Transportation Capital Grant Program, administered by the Washington State Department of Transportation, aims to fund cost-effective capital projects for transit authorities. Its core mission is to reduce the carbon intensity of Washington's transportation system, aligning with broader climate action efforts supported by the state's Climate Commitment Act (CCA). The CCA's strategic priority is to decrease climate pollution, create jobs, and enhance public health, making this grant a direct mechanism to achieve these goals by investing in sustainable transportation solutions. The primary beneficiaries of this program are transit agencies within Washington state, including various city, county, metropolitan, public, unincorporated, regional, and special purpose district transit systems. The impact goals are centered on transforming public transportation infrastructure to be more environmentally friendly. This includes the electrification of transit vehicle fleets and the development of necessary supporting infrastructure, such as charging and fueling stations, and associated electrical system upgrades. The program prioritizes capital projects that directly contribute to fleet electrification and the transition to zero-emission transportation. Eligible projects encompass the acquisition of battery and fuel cell-operated electric vehicles, modification of facilities for electrification or hydrogen refueling, and the construction of new facilities that primarily support electrified fleets. Additionally, it covers essential upgrades to electrical transmission and distribution systems, in-house staff managing capital construction, and property rights acquisition for these projects. The expected outcomes and measurable results include a significant reduction in carbon emissions from the Washington transportation sector, directly contributing to the state's climate goals. Historically, the program has awarded between $12 million and $50 million per biennium, indicating a substantial investment in achieving these outcomes. The project period for most applications is two years (July 1, 2025 – June 30, 2027), with construction projects potentially extending to four years, allowing for tangible progress in transitioning to green transportation.

Not Available

This funding opportunity provides financial support for new researchers from diverse backgrounds to conduct small-scale health-related studies, helping them advance towards independent research careers.

This Notice of Funding Opportunity (NOFO) invites applications for Diabetes Research Centers (DRCs) that are designed to support and enhance the national research effort in diabetes, its complications, and related endocrine and metabolic diseases. The purpose of this Centers program is to bring together basic and clinical investigators to enhance communication, multidisciplinary collaboration, and effectiveness of ongoing research in Diabetes Research Center topic areas. By providing shared access to specialized technical resources (research cores) and supporting a Pilot and Feasibility Program (P and F), DRCs are intended to create an environment that provides the capability for accomplishments greater than those that would be possible by individual research project grant support alone. New Center programs that bring in diverse perspectives, propose unique scientific themes, or provide innovative resources are encouraged. Emphasis will be placed on Center programs that propose enhanced synergies with other NIDDK-funded programs as well as providing a rich mentoring environment for future diabetes researchers. This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn. Applicants are strongly encouraged to read the NOFO instructions carefully and view the available PEDP guidance material.

The Chautauqua County Tourism Product Development Grant Program, with a deadline of 10/01/2024, offers $10,000 to $100,000 for projects that enhance tourism and recreation opportunities, increase visibility, and promote overnight stays in the county, with a focus on event development, marketing, and attraction enhancement.

The Minnesota Department of Agriculture (MDA) is offering the AGRI Value-Added Grant, a reimbursement grant ranging from $100,000 to $500,000, to support value-added businesses such as bioenergy producers and hemp processors in increasing sales of Minnesota agricultural products through investment in equipment, production capacity, market diversification, and market access.

This grant provides funding to nonprofit organizations in Frederick County to address critical community needs such as housing insecurity, public health, quality of life initiatives, and cultural enrichment through the arts.

This funding opportunity provides financial support to Connecticut municipalities and regional entities for projects that improve waste management infrastructure and promote recycling and waste reduction initiatives.

The Cow Creek Umpqua Indian Foundation offers grant opportunities for nonprofit 501(c)(3) organizations and local governmental bodies within Douglas County, Oregon. Focusing on Basic Needs, Abuse Prevention and Intervention, Education, Health and Wellness, and Community Support, the Foundation aims to fund projects that have a significant impact within the communities of Coos, Deschutes, Douglas, Jackson, Josephine, Klamath, and Lane Counties. With a maximum grant amount of $15,000. The Foundation emphasizes support for small grants that contribute meaningfully to the project or program, limiting organizations to one proposal per year unless specified otherwise. A final report is required from all grantees before reapplying. Grant renewed every year. Grant Annual Fall opening/closing deadlines: March 2nd to September 1st

The FY24 BCRP Clinical Research Extension Award is designed to enhance the impact of previously funded breast cancer clinical studies by extending or expanding data collection, follow-up, and analysis. This mechanism directly aligns with the broader mission of maximizing the value of breast cancer patient participation in clinical research, thereby addressing knowledge gaps that may arise from early trial termination, limited patient follow-up, or insufficient data collection and analysis. By ensuring that the invaluable contributions of patient tissues, serum, other biological specimens, and data are fully utilized, the BCRP aims to ensure that scientific efforts truly value these contributions and maximize their impact in saving lives. The primary target beneficiaries of this award are breast cancer patients and the scientific community. The impact goals are to increase the clinically relevant impact of breast cancer patient participation, accelerate progress toward ending breast cancer, and generate meaningful hypotheses or support valid conclusions. The program prioritizes research that extends or affects the impact of previous clinical trials or studies, or creates new impact in the fight against breast cancer. It specifically encourages innovative research in nuclear medicine to support early diagnosis, more effective treatment, and improved health outcomes for active-duty Service Members, Veterans, military beneficiaries, and the American public. Key focuses for the research scope include deeper molecular analysis of clinical samples, initiation of new correlative studies, biomarker validation, or continued clinical follow-up of patients in open, ongoing, or completed clinical trials. The proposed research can be hypothesis-testing or -generating, and may also be designed to create clinically annotated and molecularly characterized experimental platforms, such as patient-derived models or tissue arrays. Innovation is not a primary criterion for this award, and projects proposing new clinical trials will not be supported. A critical focus is on meaningful and productive partnerships between investigators, with a Partnering PI Option available to accommodate two Principal Investigators who bring distinct and equally intellectual contributions to the project. Expected outcomes include increased understanding of breast cancer through extended data analysis, validation of biomarkers, improved patient follow-up, and the development of new experimental platforms. Measurable results are tied to valid conclusions from appropriately sized study samples and a clear data-sharing plan to ensure the scientific community has access to generated platforms and molecular data. The program also emphasizes robust research teams with relevant expertise and mandatory involvement of two or more breast cancer consumer advocates who provide objective input on the research's potential impact for individuals with, or at risk for, breast cancer. The overall strategic priority is to accelerate clinical and translational research, especially for advanced state and recurrent patients, and to improve health outcomes for military service members and the public through relevant collaborations and innovative techniques.

This funding opportunity provides financial support to nonprofit organizations and local government units in McLean County, Illinois, to enhance health and well-being initiatives that address health equity and social determinants of health for underserved populations.

The Catholic Foundation of Michigan's grant program is designed to inspire charitable giving and support Catholic parishes, schools, and nonprofit organizations. The Foundation's core mission is to assist donors in investing in the future of these entities by providing grants that align with Catholic teachings and serve communities primarily in Michigan. The program seeks to empower organizations whose values and behaviors are consistent with Catholic principles, ensuring that funded projects contribute to the broader goals of the Catholic faith community. The grant program targets a wide range of beneficiaries within the Catholic sphere, including Archdiocesan, religious, or parish-sponsored nonprofit organizations, local nonprofit organizations adhering to Catholic Social Teaching, and various Catholic educational and formation initiatives. The overarching impact goal is to strengthen the Catholic community in Michigan by addressing vital social service needs, fostering vibrant parish life, and enhancing Catholic education and spiritual development across all ages. The program aims to create a strong, welcoming, and supportive environment for individuals to encounter Christ and grow in their faith. The Foundation focuses its grants on three major areas: Empowering Social Outreach, Building Vibrant Parish Life, and Fostering Catholic Education and Formation. In social outreach, the priority is to respond to essential social service needs such as food, shelter, and medicine, leveraging both internal and external organizations aligned with Catholic Social Teaching. For vibrant parish life, the focus is on creating welcoming Catholic parishes, supporting resource development for community outreach, and encouraging training and new staff positions. In Catholic education and formation, priorities include supporting innovative faith formation, fostering high-quality ministries for various age groups, improving access to parochial schools, and promoting leadership development. The expected outcomes of the grant program are multifaceted, aiming for tangible improvements in the communities served. Measurable results could include increased access to social services for vulnerable populations, enhanced participation and engagement in parish activities, and improved quality and accessibility of Catholic educational and spiritual development programs. The Foundation's strategic priorities are rooted in the Gospel call to serve others, the importance of the parish as a faith community's home, and the value of lifelong Catholic education and formation. This theory of change suggests that by investing in these key areas, the Foundation can contribute to a more robust, compassionate, and spiritually enriched Catholic presence throughout Michigan.

The objective of this research proposal is to develop physiologically based pharmacokinetic (PBPK) model-based mechanistic in vitro in vivo correlations (IVIVCs) for two major types of long acting injectables (LAIs) such as crystalline suspensions and polymer-based implants by considering their distinct characteristics. The goal of the project is to develop a bottom-up mechanistic PBPK model for these two LAI categories by accounting for the influence of critical formulation attributes of each LAI drug product type to predict its in vivo release mechanism. The model formulation parameters and relevant physiology should be informed with suitable in vitro and in vivo experiments. A suitable preclinical animal model can be used to validate the PBPK model based IVIVCs for both LAI suspensions and polymer based implants. The use of PBPK modelling provides a unique opportunity to understand how the physicochemical properties of drug molecules/polymer, implant specific properties, critical formulation attributes, and physiology, among other things, influence the in vivo release mechanisms of LAI drug products and their disposition characteristics. Moreover, once developed, a mechanistic PBPK model can help to define the 'safe space' for critical formulation attributes relevant to the reference listed drug (RLD) product, explain sources of PK variability and extrapolate predictions to human subjects by leveraging animal model data and by accounting for species-specific physiological differences.